Twist Bioscience Corporat... (TWST)
40.27
-1.31 (-3.15%)
At close: Mar 28, 2025, 3:59 PM
38.73
-3.84%
Pre-market: Mar 31, 2025, 07:33 AM EDT
Twist Bioscience Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 226.32M | 286.47M | 378.69M | 465.83M | 93.67M | 46.73M | 80.76M | 31.23M | 28.6M |
| Short-Term Investments | 50.08M | 49.94M | 126.28M | 12.03M | 196.34M | 91.37M | n/a | 30.98M | 27.32M |
| Long-Term Investments | n/a | n/a | 1.57M | 1.53M | 579K | 579K | 579K | 202K | 322K |
| Other Long-Term Assets | 5.91M | 8.49M | 4.96M | 9.2M | 3.4M | 4.38M | 5.94M | 896K | 536K |
| Receivables | 34.9M | 44.06M | 40.29M | 28.55M | 26.38M | 12.1M | 5.42M | 2.35M | 723K |
| Inventory | 24.08M | 32.06M | 39.31M | 31.8M | 12.29M | 7.33M | 6.03M | 1.83M | 1.23M |
| Other Current Assets | 11.4M | 11.72M | 23.83M | 16.57M | 12.41M | 2.59M | 6.73M | 1.49M | 1.17M |
| Total Current Assets | 346.78M | 424.26M | 596.48M | 546.5M | 334.87M | 160.13M | 95.67M | 67.87M | 59.04M |
| Property-Plant & Equipment | 161.35M | 203.36M | 214.39M | 105.7M | 59.16M | 20.84M | 12.33M | 14.83M | 14.62M |
| Goodwill & Intangibles | 100.29M | 140.29M | 145.55M | 40.7M | 1.45M | 1.65M | 1.85M | 2.06M | 2.27M |
| Total Long-Term Assets | 267.55M | 352.15M | 364.89M | 155.6M | 64.01M | 26.86M | 20.12M | 17.79M | 17.42M |
| Total Assets | 614.32M | 776.4M | 961.38M | 702.1M | 398.88M | 186.99M | 115.79M | 85.66M | 76.46M |
| Account Payables | 1.63M | 14.05M | 20.09M | 14.9M | 4.83M | 9.76M | 7.53M | 2.85M | 2.34M |
| Deferred Revenue | 2.13M | n/a | 3.48M | 28.76M | 18.85M | 16.44M | 7.57M | n/a | 4.62M |
| Short-Term Debt | 29.61M | 14.9M | 27.28M | 17.98M | 16.15M | 3.33M | 2.5M | n/a | 1.37M |
| Other Current Liabilities | 34.91M | 40M | 36.15M | 27.73M | 14.33M | 17.26M | 8.51M | 6.63M | 4.97M |
| Total Current Liabilities | 71.01M | 73.32M | 90.66M | 63.05M | 36.03M | 30.35M | 18.54M | 9.48M | 8.68M |
| Long-Term Debt | 70.22M | 79.17M | 81.27M | 53.16M | 26.24M | 4.4M | 7.22M | 9.15M | 9.81M |
| Other Long-Term Liabilities | 407K | 475K | 60K | 5.07M | 351K | 158K | 291.46M | 200.38M | 134.58M |
| Total Long-Term Liabilities | 70.63M | 79.65M | 81.33M | 58.22M | 26.59M | 4.56M | 298.68M | 209.54M | 144.4M |
| Total Liabilities | 141.63M | 152.97M | 171.99M | 121.28M | 62.62M | 34.91M | 317.21M | 219.01M | 153.07M |
| Total Debt | 85.03M | 94.07M | 94.91M | 62.92M | 35.98M | 7.73M | 9.72M | 9.15M | 11.18M |
| Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Retained Earnings | -1.24B | -1.03B | -828.42M | -610.55M | -458.45M | -318.52M | -210.85M | -139.62M | -80.31M |
| Comprehensive Income | -522K | -756K | -1.84M | 546K | 87K | 181K | 87K | 33K | 9K |
| Shareholders Equity | 472.69M | 623.43M | 789.38M | 580.82M | 336.26M | 152.08M | -201.42M | -133.36M | -76.61M |
| Total Investments | 50.08M | 49.94M | 126.28M | 12.03M | 196.34M | 91.37M | 579K | 30.98M | 27.32M |